№ lp_2_1_30065
File format: docx
Character count: 3773
File size: 17 KB
Medical emergency protocol outlining recognition, weight-based epinephrine administration, monitoring procedures, and emergency response steps for anaphylaxis occurring in school settings.
Title:
Severe Allergic Reaction – Anaphylaxis Protocol
Type of Document:
Medical Emergency Protocol
Subject:
Anaphylaxis Management
Setting:
School and School-Related Events
Target Population:
Children and Adults
Primary Medication:
Epinephrine
Additional Medication:
Albuterol Sulfate Inhalation Solution 0.083% (2.5mg/3ml)
Emergency Response:
EMS (911) Activation Required
Monitoring Requirements:
Heart Rate, Respiratory Status, pO2, Level of Consciousness
Equipment Referenced:
AED, Portable Oxygen, Ambu Bag, Pulse Oximeter, Nebulizer
Approval Authority:
Physician
Effective Date:
Not Specified
Issuing Entity:
School/District
Documentation Required:
Incident Report and Nursing Documentation
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Europe
Topic:
Allergen immunotherapy, allergic asthma, house dust mites
Document Type:
Clinical guideline
Organization / Institution:
European Academy of Allergy and Clinical Immunology (EAACI)
Authors:
I Agache, S Lau, CA Akdis, S Smolinska, M Bonini, O Cavkaytar, B Flood, P Gajdanowicz, K Izuhara, Ö Kalayci, R Mosges, O Palomares, N Papadopoulos, M Sokolowska, E Angier, M Fernandez-Rivas, G Pajno, O Pfaar, G Roberts, D Ryan, G Sturm, R van Ree, EM Varga, R Gerth van Wijk, JJ Yepes – Nuñez, M Jutel
Target Audience:
Healthcare professionals (doctors, researchers, allergy specialists)
Date Approved:
2023
Date of Revisions:
N/A
Year:
2021
Region / city:
United States
Topic:
Anaphylaxis, Epinephrine Auto-Injector, Emergency Action Plan
Document Type:
Procedure
Organization / Institution:
School, Healthcare Providers
Author:
Bingemann, T.A., Nanda, A., Russell, A.F., Butler, S.M., Boucher, E.A., Tobison, J., Phan, H., Campbell, R.L., Kelso, J.M.
Target Audience:
School Nurses, School Staff, Healthcare Providers
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Note:
Contextual Description
Year:
2023
Region / City:
Not specified
Topic:
Allergic conjunctivitis treatment
Document type:
Patient information leaflet
Author:
Ms. Alice Milligan
Target audience:
Patients suffering from allergic conjunctivitis
Approval date:
May 2023
Review date:
May 2025
Year:
2023
Region / city:
United Kingdom
Theme:
Healthcare, Allergies, Treatment Guidelines
Document type:
Patient Group Direction (PGD)
Organization:
NHS
Author:
Not specified
Target audience:
Healthcare professionals
Effective period:
Ongoing
Approval date:
Not specified
Modification date:
Not specified
Year:
2023
Region / City:
Beijing, China
Subject:
Allergic diseases, monoclonal antibody therapy, clinical trials
Document Type:
Supplementary data
Institution:
Capital Medical University, Department of Immunology
Authors:
Yan Chen, Wei Wang, Huihui Yuan, Yan Li, Zhe Lv, Ye Cui, Jie Liu, Sun Ying
Target Population:
Children, adolescents, and adults with allergic asthma
Trial Duration:
12–60 weeks
Primary Outcomes:
Treatment safety, efficacy, quality of life, pulmonary function, IgE levels
Sample Size Range:
19–4308 participants
Medications Studied:
Omalizumab
Study Design:
Controlled clinical trials with specific inclusion criteria for allergic asthma patients
Year:
2022
Journal:
World Journal of Clinical Cases
Manuscript Type:
Case Report
Authors:
Miao Zhang, Jia Chen, Chun-Xiao Wang, Nai-Xuan Lin, Xin Li
Affiliations:
Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine; Department of Dermatopathology, Shanghai Skin Disease Hospital, Tongji University
Corresponding Author:
Xin Li, MD, PhD
Received Date:
May 31, 2022
Revised Date:
July 9, 2022
Accepted Date:
August 23, 2022
Published Online:
2022
Keywords:
Vitamin K1, Subcutaneous injection, Adverse reactions, Herbal medicine, Polyoxyethylated castor oil, Case report guidelines
Target Audience:
Clinicians, Dermatologists, Researchers in clinical medicine
Patient Age:
50 years
Patient Condition:
Cutaneous allergic reaction to vitamin K1
Treatment:
Chinese herbal medicine, topical and intralesional steroids
Follow-up Duration:
32 months
Year:
Not specified
Region / city:
Not specified
Topic:
Seasonal Allergic Rhinitis, Treatment Guidelines
Document type:
Medical guideline
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals (GPs, clinicians)
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Document type:
Clinical skills evaluation forms
Purpose:
Annual verification of provider proficiency
Clinical domains:
Airway management, ventilation, anaphylaxis treatment, cardiac arrest management
Procedures assessed:
BVM ventilations, epinephrine administration, CPR and AED use
Evaluation method:
Task-based point scoring
Total points (BVM ventilation):
9
Total points (Anaphylaxis management):
11
Total points (Cardiac arrest management):
24
Target audience:
Emergency medical providers and responders
Scenarios included:
Respiratory failure, anaphylaxis from insect sting, adult cardiac arrest
Roles referenced:
Rescuer, evaluator, lead medic
Source type:
Training and competency assessment records
Year:
2024
Region / city:
United Kingdom
Topic:
Anaphylaxis management and treatment
Document type:
Policy
Organization:
Trust (Healthcare institution)
Author:
Resuscitation Lead
Target audience:
Healthcare professionals, clinicians
Effective period:
January 2025 to November 2027
Approval date:
28th November 2024
Ratification date:
22nd January 2025
Last review date:
November 2024
Next review date:
November 2027
Year:
2021
Region / City:
Victoria, Australia
Subject:
First Aid, Anaphylaxis Management
Document Type:
Course Accreditation
Organization / Institution:
Department of Education and Training (Victoria)
Author:
Department of Education and Training (Victoria)
Target Audience:
Individuals responsible for others in the workplace (adults and/or children) who have been diagnosed as being at risk of anaphylaxis
Period of Effect:
1 July 2021 to 30 June 2026
Approval Date:
1 July 2021
Modification Date:
Not specified
Note:
Year
Document Type:
Lesson Plan
Target Audience:
Students
Year:
2021
Region / City:
Canberra, Australia
Theme:
Medical Emergency, Anaphylaxis Management
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Unknown
Target Audience:
Healthcare Providers, Medical Officers, Registered Nurses, Midwives, Podiatrists, Community Nurses
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2021
Region / city:
Victoria, Australia
Subject:
First Aid, Anaphylaxis Management
Document Type:
Course Accreditation
Organization:
Department of Jobs, Skills, Industries and Regions (DJSIR), Victoria
Author:
Department of Jobs, Skills, Industries and Regions (DJSIR)
Target Audience:
Individuals responsible for the safety of others at risk of anaphylaxis in the workplace
Period of validity:
1 July 2021 to 30 June 2026
Approval Date:
17 March 2021
Amendment Date:
November 2024
Year:
2021
Region / city:
United States
Topic:
Anaphylaxis, Epinephrine Auto-Injector, Emergency Action Plan
Document Type:
Procedure
Organization / Institution:
School, Healthcare Providers
Author:
Bingemann, T.A., Nanda, A., Russell, A.F., Butler, S.M., Boucher, E.A., Tobison, J., Phan, H., Campbell, R.L., Kelso, J.M.
Target Audience:
School Nurses, School Staff, Healthcare Providers
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Note:
Contextual Description
Year:
2026
Region / City:
New York
Topic:
Allergy and Anaphylaxis Management
Document Type:
Emergency Plan
Organization:
New York State Office of Children and Family Services
Author:
Unknown
Target Audience:
Parents, Guardians, Child Care Providers
Action Period:
Ongoing, reviewed annually
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Topic:
Emergency response, anaphylaxis
Document Type:
Emergency protocol
Target Audience:
Clinical staff, reception staff
Note:
Year
Topic:
Workplace health and safety
Document type:
Risk assessment form
Target audience:
Employees, workplace managers